Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

No Islet Cell Hyperfunction, but Altered Gut-Islet Regulation and Postprandial Hypoglycemia in Glucose-Tolerant Patients 3 Years After Gastric Bypass Surgery

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Genetic Determinants of Weight Loss After Bariatric Surgery

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Plasma FGF-19 Levels are Increased in Patients with Post-Bariatric Hypoglycemia

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Bone health in patients with type 2 diabetes treated by Roux-En-Y gastric bypass and the role of diabetes remission

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. The Impact of Upper Abdominal Pain During Pregnancy Following a Gastric Bypass

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Vagal Blocking for Obesity Control: a Possible Mechanism-Of-Action

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Adults with pathogenic MC4R mutations have increased final height and thereby increased bone mass

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Assessment of Islet Alpha- and Beta-Cell Function

    Publikation: Bidrag til bog/antologi/rapportBidrag til bog/antologiFormidling

Vis graf over relationer

Postprandial hyperinsulinemia characterizes Roux-en-Y gastric bypass (RYGB) and sometimes leads to reactive hypoglycemia. We prospectively evaluated changes in beta cell function in seven RYGB-operated patients with a median follow-up of 2.9 years with hyperglycemic clamps and oral glucose tolerance tests (OGTTs). Three years after RYGB, weight loss was 26 % and insulin sensitivity had improved. Insulin secretion during clamp experiments was largely unchanged compared to before surgery. In contrast, insulin secretion in response to the OGTTs doubled when evaluated by the disposition index and 2-h plasma glucose declined to a mean of 3.3 ± 0.3 mmol/l postoperatively. Our findings indicate that intrinsic beta cell function remains unchanged in glucose-tolerant patients even years after RYGB, while altered gut-islet regulation drive risk of postprandial hyperinsulinemic hypoglycemia.

OriginalsprogEngelsk
TidsskriftObesity Surgery
Vol/bind26
Udgave nummer9
Sider (fra-til)2263-7
Antal sider5
ISSN0960-8923
DOI
StatusUdgivet - nov. 2016

ID: 49150144